♨️♨️♨️ Hot of the press: Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study https://t.co/XQBswA3IIJ
@ProfJDChalmers@EuroRespSoc#bronchiectasis
The 2025 GOLD Report, Pocket Guide and Teaching Slides are now available for download!
This year's update includes content on:
*Cardiovascular risk
*CT imaging
*Pharmacotherapy, including ensifentrine and dupilumab
*ICS withdrawal
*Spirometry, including comprehensive information on LLN, z-scores and reference values
*Climate change
Download at https://t.co/QnYxOPf8fr!
#COPD
@KingsResp@instagram Seems like B?
Cysts not that big, but features of GGOs in compatible areas with no subpleural sparing or subpleural honeycombing. Tbh clinical scenario compatible with possible sjogren influenced the answer.
@KingsResp I'd agree with others who said E. Max work and VO2 not reached, but might be due to respiratory limitation. For IC to drop (TV+IRV), the FRC must be increasing like in trapping. Usually TV increases by getting IRV and ERV in CPET.
Maybe looking at exercise tidal loop would help
@KingsResp Thank you for adding histopath! Great job and hope you'll continue with the questions!
Hard toss B vs E since the HE and GMS? seems to show hyphal elements. Maybe E since description of CT has central necreosis with thick wall cavity vs fungus ball? Risk factors are there too
MEET THE SPEAKERS | INSPIRE 2024 is packed with high-yield lectures from experts in pulmonary and critical care medicine. 🫁🩺
Register today! Don't miss out on our standard rates and 6+1 promo. Online registration runs until October 10, 2024 (Thursday), 12:00 nn 🇵🇭
Scan QR ⬇️
@KingsResp Seems like B is a good option.
Based on good study by Pierre-Francois group (CAPE COD trial 2023), steroids may be beneficial for patients with severe CAP, may have mortality benefit.
@nc_huan@PGH_Pulmo@scian_@PulmonaryEndos1 Excellent workshop on pleuroscopy and lectures on dry pleuroscopy and pleural diseases! Hopefully we'll be able to utilize more and more in our region! Hope to see you in future conferences @nc_huan
@genephiliplouie talks about the importance of the #asthma action plan 📝 and introduces the upcoming multidisciplinary asthma clinic together with Family Med, Allergy/Immunology & OB/GYN Perinatology colleagues. 🫁👨⚕️👩⚕️ #NationalLungMonth@philchestorg
The goal of asthma treatment should be personalized for each patient, aiming for the patient’s best possible long-term outcomes. This includes both long-term symptom control and long-term risk reduction. Assessing recent symptom control is not enough. https://t.co/GSJlSZmSTo
Today is World Asthma Day! GINA emphasizes the need to empower people with asthma with the appropriate education to manage their disease - Asthma Education Empowers.
Download the new 2024 report here: https://t.co/Y7LmqYWiiy
#WorldAsthmaDay#GINA#Asthma#AsthmaEducation
Today is #WorldPHDay2024, a day to spread awareness & raise the profile of some of the work ERS is doing within the field.
ERS CRC PHAROS: https://t.co/r3Y8p3x9Lp
ERS Guideline on PH: https://t.co/NXpU3ZOCNN
We are excited to start the month off with a new #RadiologyRounds 🫁
A young adult man in his 20s presents with dyspnea on exertion, productive cough, intermittent wheezing and general fatigue. A chest x-ray was obtained as part of his work-up.
Can’t miss episode out today with @CritCareTime@nickmmark@Askins_Razor@OnePagerICU on Bronchoscopy in the ICU.
We talk about times when the Bronch can be your best friend, or get you into, and then out of, trouble. Listen in!!
https://t.co/jusdq4gHSp
Will a detailed description of the extent and pattern of high-resolution CT scan fibrosis in patients with stage IV pulmonary #sarcoidosis impact pulmonary function and survival? Read more in the April @journal_CHEST issue: https://t.co/sOoVMBsf1K
#MedEd#SarcoidosisAwareness